GlassScriptPhysician profile
Thomas K Byrne
NPI 1972617520
$12,821.78
in general payments reported to CMS, 2019-2025
16 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2021: $7,483 · 2022: $304 · 2023: $3,401 · 2024: $808 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,137 · Food and Beverage: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,137.01 |
| Food and Beverage | $1,581.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,759.95 | 2021-2023 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $433.54 | 2019-2025 | Echelon; Endopath, Enseal, Stratafix |
| Medical Device Business Services, INC. | $282.01 | 2025 | Echelon Flex |
| Acera Surgical, INC. | $217.59 | 2021-2024 | Restrata Wound Matrix |
| W. L. Gore & Associates, INC. | $203.27 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Enterra Medical, INC. | $171.52 | 2024 | |
| Boston Scientific Corporation | $149.93 | 2024 | Spyglass Discover |
| Kerecis Limited | $144.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $107.30 | 2023 | Pico, Renasys Touch |
| Lilly USA, LLC | $88.63 | 2025 | Zepbound |
| Medtronic, INC. | $85.58 | 2024 | Plasmablade(Tm), Signia |
| Conmed Corporation | $43.05 | 2021 | |
| Teleflex LLC | $41.58 | 2025 | Quikclot |
| Depuy Synthes Sales INC. | $41.02 | 2023 | Matrixrib, Zipfix, Xcm Biologic Tissue Matrix |
| Baxter Healthcare | $32.37 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $20.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Byrne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.